ArriVent BioPharma Statistics
Total Valuation
AVBP has a market cap or net worth of $1.07 billion. The enterprise value is $759.20 million.
| Market Cap | 1.07B |
| Enterprise Value | 759.20M |
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AVBP has 33.59 million shares outstanding. The number of shares has increased by 994.78% in one year.
| Current Share Class | 33.59M |
| Shares Outstanding | 33.59M |
| Shares Change (YoY) | +994.78% |
| Shares Change (QoQ) | +33.76% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 39.82% |
| Float | 16.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 25.50, with a Debt / Equity ratio of 0.00.
| Current Ratio | 25.50 |
| Quick Ratio | 24.75 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -31.03% and return on invested capital (ROIC) is -22.31%.
| Return on Equity (ROE) | -31.03% |
| Return on Assets (ROA) | -21.22% |
| Return on Capital (ROIC) | -22.31% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.87M |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 27.03 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 62.72 |
| Average Volume (20 Days) | 125,621 |
Short Selling Information
The latest short interest is 3.41 million, so 10.14% of the outstanding shares have been sold short.
| Short Interest | 3.41M |
| Short Previous Month | 3.35M |
| Short % of Shares Out | 10.14% |
| Short % of Float | 21.19% |
| Short Ratio (days to cover) | 10.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -86.21M |
| Pretax Income | n/a |
| Net Income | -74.89M |
| EBITDA | n/a |
| EBIT | -86.21M |
| Earnings Per Share (EPS) | -$4.69 |
Balance Sheet
The company has $298.67 million in cash and $250,000 in debt, giving a net cash position of $298.42 million or $8.89 per share.
| Cash & Cash Equivalents | 298.67M |
| Total Debt | 250,000 |
| Net Cash | 298.42M |
| Net Cash Per Share | $8.89 |
| Equity (Book Value) | 296.66M |
| Book Value Per Share | 8.85 |
| Working Capital | 296.41M |
Cash Flow
| Operating Cash Flow | -68.07M |
| Capital Expenditures | n/a |
| Free Cash Flow | -68.07M |
| FCF Per Share | -$2.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -994.78% |
| Shareholder Yield | -994.78% |
| Earnings Yield | -7.08% |
| FCF Yield | -6.44% |
Analyst Forecast
The average price target for AVBP is $36.80, which is 15.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.80 |
| Price Target Difference | 15.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |